XML 1097 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Accounting Policies [Abstract]    
Calculation of net loss and number of shares used to compute basic and diluted earnings per share

Basic net loss per share is determined by dividing net loss by the weighted average shares of common stock outstanding during the period, without consideration of potentially dilutive securities except for those shares that are issuable for little or no cash consideration. Diluted net loss per share is determined by dividing net loss by diluted weighted average shares outstanding. Diluted weighted average shares reflects the dilutive effect, if any, of potentially dilutive common shares, such as stock options and warrants calculated using the treasury stock method. In periods with reported net operating losses, all common stock options and warrants are generally deemed anti-dilutive such that basic net loss per share and diluted net loss per share are equal. However, in certain periods in which the exercise price of the warrants was less than the last reported sales price of Delcath’s common stock on the final trading day of the period and there is a gain recorded pursuant to the change in fair value of the warrant derivative liability, the impact of gains related to the mark-to-market adjustment of the warrants outstanding at the end of the period is reversed and the treasury stock method is used to determine diluted earnings per share.

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
(in thousands, except share data)    2019      2018      2019     2018  

Net (loss) income—basic

   $ (7,519    $ (8,880    $ (21,371   $ (8,353

Preferred stock dividends

     (18,238      —          (18,238     —    

Adjustment for gain on warrant income

     —          (13      —         (534
  

 

 

    

 

 

    

 

 

   

 

 

 

Net loss—diluted

   $ (25,757    $ (8,893    $ (39,609   $ (8,887

Weighted average shares outstanding—basic*

     26,112        51,229        23,095       19,841  
  

 

 

    

 

 

    

 

 

   

 

 

 

Weighted average shares outstanding—diluted*

     26,112        51,229        23,095       19,841  
  

 

 

    

 

 

    

 

 

   

 

 

 

Net loss per share—basic*

   $ (287.00    $ (175.00    $ (924.00   $ (420.00

Net loss per share—diluted*

   $ (987.00    $ (175.00    $ (1,715.00   $ (448.00

 

  *

reflects a one-for-five hundred (1:500) reverse stock split effected on May 2, 2018 and a one-for-seven hundred (1:700) reverse stock split effected on December 24, 2019.

The calculation of net loss and the number of shares used to compute basic and diluted earnings per share for the years ended December 31, 2018 and 2017:

 

     December 31,  
(in thousands, except share data)    2018      2017  

Net loss—basic

   $ (19,222    $ (45,117

Preferred stock dividends

     —        (527
  

 

 

    

 

 

 

Net loss—diluted

   $ (19,222    $ (45,644
  

 

 

    

 

 

 

Weighted average shares outstanding—basic

     38,151        21  
  

 

 

    

 

 

 

Weighted average shares outstanding—diluted

     38,151        21  
  

 

 

    

 

 

 

Net loss per share—basic

   $ (504.00    $ (2,275,000

Net loss per share—diluted

   $ (504.00    $ (2,275,000

Summary of Reconciliation of Weighted Average Shares Outstanding Calculation  

The following table provides a reconciliation of the weighted average shares outstanding calculation at December 31, 2018:

 

     December 31,
2018
 

Weighted average shares issued

     3,913  

Weighted average pre-funded warrants

     34,238  
  

 

 

 

Weighted average shares outstanding

     38,151  
  

 

 

 
Anti-dilutive securities excluded from the computation of earnings per share

The following potentially dilutive securities were excluded from the computation of earnings per share as of September 30, 2019 and 2018 because their effects would be anti-dilutive:

 

     September 30,  
     2019      2018  

Stock options

     1,643        —  

Common stock warrants—equity

     —        6,005  

Common stock warrants—liability

     1,001,963        1,429  

Assumed conversion of Series E and E-1 Preferred Stock

     1,001,963        —  

Assumed conversion of convertible notes

     31,747        8,057  
  

 

 

    

 

 

 

Total

     2,037,316        15,491  
  

 

 

    

 

 

 

Shares excluded from the computation of diluted earnings per share:

 

     2018      2017  

Common stock warrants—equity

     6,005        21  

Common stock warrants—liability

     271        —  

Assumed conversion of convertible notes

     3,681        —  
  

 

 

    

 

 

 

Total

     9,957        21